Medicare Enrolled

Dr. Shelley Singh, D.O.

Rheumatology · Delray Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
14610 S MILITARY TRL STE G3, Delray Beach, FL 33484
5618193100
In practice since 2014 (12 years)
NPI: 1750702171 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Shelley Singh is a rheumatology in Delray Beach, FL, with 12 years in practice. Based on federal Medicare data, Dr. Singh performed 119,856 Medicare services across 4,287 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $10,346 from 40 pharmaceutical and/or device companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 20% volume in FL$ $10,346 industry payments

Medicare Practice Summary

Medicare Utilization ↗
119,856
Medicare services
Top 20% in FL for rheumatology
4,287
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,988 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)58,800$4$21
Denosumab injection (Prolia/Xgeva)18,060$18$53
Romosozumab injection (Evenity) for osteoporosis17,850$8$24
Abatacept infusion (Orencia)6,650$34$134
Golimumab infusion (Simponi Aria)6,350$11$59
Steroid injection (triamcinolone)4,990$1$4
Office visit, established patient (30-39 min)1,616$99$338
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle952$59$232
Methotrexate sodium, 5 mg586$0$1
Blood draw (venipuncture)439$8$21
Ultrasonic guidance for needle placement390$48$380
Aspiration and/or injection of fluid large joint using ultrasound guidance353$92$364
Injection into tendon or ligament311$43$220
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month286$51$200
X-ray of hand, minimum of 3 views236$30$96
Betamethasone steroid injection230$5$18
Administration of chemotherapy into vein, 1 hour or less184$107$479
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)145$51$166
New patient office visit (45-59 min)119$128$533
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose103$59$380
X-ray of lower and sacral spine, 2-3 views95$31$105
Drug injection, under skin or into muscle89$11$73
Limited ultrasound scan of joint or other extremity structure except blood vessels87$35$147
Foot X-ray, 3+ views78$28$91
Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve69$37$439
Office visit, established patient (20-29 min)69$71$238
Aspiration and/or injection of fluid from small joint using ultrasound guidance65$74$283
Shoulder X-ray, 2+ views65$29$91
X-ray of knee, 1-2 views58$27$90
X-ray of pelvis, 1-2 views54$22$73
Aspiration and/or injection of fluid from medium joint using ultrasound guidance50$90$344
Complete ultrasound scan of joint46$45$242
Knee X-ray, 3 views45$34$107
Injection of additional new drug or substance into vein44$13$62
Hip X-ray, 2-3 views41$39$123
Injection of trigger points, 1-2 muscles39$29$172
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month35$39$140
Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)27$132$443
X-ray of both knees while standing26$33$106
X-ray of upper spine, 4-5 views25$42$139
Administration of chemotherapy into vein, each additional hour24$23$104
Injection, methylprednisolone sodium succinate, up to 125 mg20$4$17
Injection, diphenhydramine hcl, up to 50 mg19$1$3
X-ray of both hips, 3-4 views13$41$140
X-ray of middle spine, 2 views12$25$86
X-ray of elbow, 2 views11$24$77
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.8% high complexity
85.4% medium
3.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,346
Total received (2018-2024)
Avg $1,478/year across 7 years
Top 41% in FL for rheumatology
40
Companies
620
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,346 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,257
2023
$1,503
2022
$1,768
2021
$1,739
2020
$1,087
2019
$1,892
2018
$1,099

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,798
UCB, Inc.
$1,531
E.R. Squibb & Sons, L.L.C.
$893
Janssen Biotech, Inc.
$692
Radius Health, Inc.
$689
PFIZER INC.
$615
Novartis Pharmaceuticals Corporation
$600
AbbVie Inc.
$496
AstraZeneca Pharmaceuticals LP
$464
Janssen Scientific Affairs, LLC
$449
AbbVie, Inc.
$290
GlaxoSmithKline, LLC.
$221
ABBVIE INC.
$149
Sobi, Inc
$139
SANOFI-AVENTIS U.S. LLC
$117
Lilly USA, LLC
$116
SCILEX PHARMACEUTICALS INC.
$113
GENZYME CORPORATION
$103
Mallinckrodt Hospital Products Inc.
$94
Horizon Therapeutics plc
$90
DePuy Synthes Sales Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$76
Pacira Pharmaceuticals Incorporated
$75
SOBI, INC
$73
Genentech USA, Inc.
$40
Bioventus LLC
$40
Alkermes, Inc.
$40
Mallinckrodt Enterprises LLC
$30
Merck Sharp & Dohme Corporation
$28
Alexion Pharmaceuticals, Inc.
$27
ANI Pharmaceuticals, Inc.
$26
Horizon Pharma plc
$25
Zimmer Biomet Holdings, Inc.
$20
Organon Llc
$19
Mallinckrodt LLC
$16
Flexion Therapeutics, Inc.
$15
Hikma Pharmaceuticals USA
$14
West-Ward Pharmaceuticals
$13
Organon LLC
$13
Endo Pharmaceuticals Inc.
$12
Top 3 companies account for 40.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ARISTADA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · Entyvio · Exparel · FORTEO · GPS III PLATELET CONCENTRATION SYSTEM · HADLIMA · HUMIRA · Humira · ILARIS · INFLECTRA · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LYBALVI · LYRICA · MONOVISC · Mitigare · ORENCIA · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SUPARTZ FX SODIUM HYALURONATE · Strensiq · Supartz FX Sodium Hyaluronate · TALTZ · TREMFYA · Tymlos · Uloric · XELJANZ · XIAFLEX · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $9 per 100 Medicare services performed
Looking for a rheumatology in Delray Beach?
Compare rheumatologys in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
58
Per 100K population
3.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Singh is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Singh performed 58,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $10,346 from 40 companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other rheumatologys in Delray Beach?
Dr. Singh's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →